This company provides digitally-enabled specialty healthcare focused on serious mental illnesses like schizophrenia and bipolar disorder. They apply data-driven methods and precision medicine principles to improve treatment outcomes for complex psychiatric conditions. The platform aims to optimize medication selection, manage polypharmacy, and increase access to expert psychiatric care.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with serious mental illnesses, such as schizophrenia and bipolar disorder, face challenges in medication selection and adherence, leading to poor health outcomes and high healthcare costs. Trial-and-error approaches to medication management, compounded by co-occurring mental health conditions, contribute to these difficulties. High rates of medication non-adherence further exacerbate the problem, resulting in emergency room visits and hospitalizations.
Solution
Altimate Health leverages artificial intelligence and precision medicine to improve medication selection and adherence for individuals with serious mental illnesses. The company's data-driven products aim to optimize treatment strategies, addressing the complexities of polypharmacy and co-morbid mental health conditions. By applying AI and precision medicine, Altimate Health seeks to enhance access to psychiatric care, particularly for vulnerable populations, and reduce avoidable healthcare spending associated with medication mismanagement and non-adherence. The company envisions a future where all patients with these conditions have access to the best available, data-informed care.
Target Audience
The primary target audience includes psychiatrists, healthcare providers, and managed care organizations involved in the treatment of patients with schizophrenia, bipolar disorder, and other serious mental illnesses.
Features
- AI-powered medication selection tools to personalize treatment plans
- Data-driven insights to manage polypharmacy and co-occurring conditions
- Predictive models to identify patients at risk of medication non-adherence